Brief: NLS Pharmaceutics Says Nasdaq Panel Grants NLS Pharmaceutics' Request For Extension To Comply With Continued Listing Requirements
25/06/2024 14:43
June 25 (Reuters) - NLS Pharmaceutics AG NLSP.O :
* NLS PHARMACEUTICS - NASDAQ PANEL GRANTS NLS PHARMACEUTICS'
REQUEST FOR EXTENSION TO COMPLY WITH CONTINUED LISTING
REQUIREMENTS
Source text for Eikon: ID:
Further company coverage: NLSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewcelX AG
See all newsBrief: Newcelx Announces Pricing Of $1.4 Million Equity Financing At 20% Premium Pricing
Brief: Newcelx Submits Pre-IND Package To FDA For NCEL-101 For Treatment Of Type 1 Diabetes
Brief: Newcelx Updates Corporate Presentation To Highlight Type 1 Diabetes Flagship Program
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing